Author:
Myers Jamie S.,Siengsukon Catherine,Sherman Joseph,Shen Xinglei,Ptomey Lauren T.,Montgomery Robert,Bock Karen,Rice Anna,Parker William P.,Maliski Sally
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Oncology (nursing),Oncology
Reference48 articles.
1. Use of androgen deprivation therapy in prostate cancer: indications and prevalence;Asian J Androl,2012
2. Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis;PLoS One,2015
3. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy;J Clin Oncol,2006
4. Cross-section observational study about prevalence of metabolic syndrome and osteoporosis in prostate cancer treated with androgen-deprivation therapy and their impact on quality of life (SIMBOSPROST): Givor group;Int J Radiat Oncol Biol Phys,2013
5. Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy;Can Urol Assoc J,2016
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献